Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. (2015)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.4409

PubMed Identifier: 26160844

Publication URI: http://europepmc.org/abstract/MED/26160844

Type: Journal Article/Review

Volume: 6

Parent Publication: Oncotarget

Issue: 27

ISSN: 1949-2553